Volume 27, Number 3—March 2021
Dispatch
Extraintestinal Seeding of Salmonella enterica Serotype Typhi, Pakistan
Seema Irfan
, Mohammad Zeeshan, Salima Rattani, Joveria Farooqi, Sadia Shakoor, Rumina Hasan, and Afia Zafar
, Mohammad Zeeshan, Salima Rattani, Joveria Farooqi, Sadia Shakoor, Rumina Hasan, and Afia Zafar
Table 1
Salmonella enterica serotype Typhi isolates from blood, feces, and urine versus other body sites, Pakistan 2013−2018
| Characteristic |
No. (%, 95% CI) in blood, feces, or urine | No. (%, 95% CI) in other body sites | Total cases | p value | |
|---|---|---|---|---|---|
| No. ceftriaxone sensitive |
5,858 (99.1, 98.9–99.4) |
51 (0.86, 0.63–1.10) |
5,909 |
0.011 |
|
| No. ceftriaxone resistant |
2,878 (99.6, 99.4–99.8) |
11 (0.38, 0.16–0.61) |
2,889 |
||
| Total |
8,736 (99.3, 99.1–99.5) |
62 (0.70, 0.53–0.88) |
8,798 |
||
| Year |
Ceftriaoxne susceptibility |
||||
| 2013 | Sensitive |
662 (98.5, 97.6–99.4) |
10 (1.49, 0.57–2.41) |
672 |
0.902 |
| Resistant |
0 |
0 |
0 |
||
| 2014 | Sensitive |
701 (98.7, 97.9–99.6) |
9 (1.27, 0.45–2.10) |
710 |
0.873 |
| Resistant |
0 |
0 |
0 |
||
| 2015 | Sensitive |
881(98.9, 98.3–99.6) |
9 (1.01, 0.36–1.68) |
890 |
0.839 |
| Resistant |
0 |
0 |
0 |
||
| 2016 | Sensitive |
1,167 (99.5, 99.2–99.9) |
5 (0.42, 0.05–0.80) |
1,172 |
0.764 |
| Resistant |
21 (100)* |
0 |
21 |
||
| 2017 | Sensitive |
1,299 (99.3, 98.9–99.8) |
9 (0.69) 24–1.14) |
1,308 |
0.057 |
| Resistant |
526 (100)* |
0 |
526 |
||
| 2018† | Sensitive |
1,155 (99.2, 98.7–99.7) |
9 (0.77, 0.27–1.28) |
1,164 |
0.264 |
| Resistant | 2,324 (99.5, 99.3–99.8) | 11 (0.47, 0.19–0.75) | 2,335 | ||
*Because 100% of extensively drug-resistant Salmonella Typhi were obtained from blood, stool, or urine, there was no 95% CI. †A total of 20 (0.57%) of 3,499 Salmonella Typhi were isolated from other body sites during 2018.
Page created: December 07, 2020
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.